HomeIndustriesHealthcareOverlooked Stock: PTGX
00:00
00:00
04:21
Overlooked Stock: PTGX

Overlooked Stock: PTGX

Protagonist Therapeutics (PTGX) rallied 45% after its latest drug trial to treat people with active ulcerative colitis saw success. George Tsilis says there's more positive catalysts behind the stock, particularly its cash pile.

Market On Close

10 Mar 2025

SHARE

ON AIR
10:00 pm
Fast Market
replay
5:00 am
Gamma On
REPLAY
5:30 am
Gamma On
REPLAY
6:00 am
Gamma On
REPLAY
6:30 am
Gamma On
REPLAY
7:30 am
Gamma On
REPLAY
8:00 am
Gamma On
REPLAY
8:30 am
Gamma On
REPLAY
9:00 am
Gamma On
REPLAY
10:00 am
Gamma On
REPLAY
11:00 am
Gamma On
REPLAY
12:00 pm
Morning Movers
1:00 pm
Morning Trade Live
3:00 pm
Trading 360
4:00 pm
Fast Market
5:00 pm
Next Gen Investing
6:00 pm
The Watch List
7:00 pm
Market On Close
8:30 pm
Market Overtime
REPLAY
9:00 pm
Trading 360
REPLAY
ON AIR
10:00 pm
Fast Market
REPLAY
11:00 pm
Next Gen Investing
REPLAY
12:00 am
Market Overtime
REPLAY
12:30 am
Market Overtime
REPLAY
1:00 am
Gamma On
REPLAY
2:00 am
Market Overtime
REPLAY
2:30 am
Market Overtime
REPLAY
education
3:00 am
Inside the Mind of a Trader
REPLAY
education
3:30 am
Inside the Mind of a Trader
REPLAY
education
4:00 am
Inside the Mind of a Trader
REPLAY
education
4:30 am
Your First Trade
REPLAY

Schwab Network's Newsletters

Daily insights for every investor